Researchers reported Thursday that in two international studies, about 1 in 5 patients given the experimental drug for six months saw their virus reduced to levels low enough that the immune system could keep it in check.
Researchers reported Thursday that in two international studies, about 1 in 5 patients given the experimental drug for six months saw their virus reduced to levels low enough that the immune system could keep it in check.
<iframe src="https://statesidedaily.com/embed/cluster/c3047c1a96b337941a3840e3597bae1e12c4472b" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Hepatitis B drug may offer 'functional cure' for some patients"></iframe>